Skip to main content

Table 3 Most frequently emerging T-cell receptor (TCR) β sequences that constituted a proportion greater than 5% of all sequences

From: V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

Sample* CDR3 amino acid sequence CDR3 length (nt) Percentage V gene J gene D gene
R1 CASSEALNNEQFF 39 17.76% TRBV2 TRBJ2–1 TRBD2
  CAKGRVPYEQYF 36 6.83% TRBV2 TRBJ2–7 TRBD2
R2 CACSASSSYEQYF 39 14.16% TRBV2 TRBJ2–7 TRBD2
  CASSYSSQEQFF 36 5.33% TRBV6–3 TRBJ2–1 TRBD1
R4 CATMGGYTF 27 7.71% TRBV6–5 TRBJ1–2 TRBD1
NR1 CASSFSPHEQYF 36 9.43% TRBV28 TRBJ2–7 TRBD1
  CASSLGSQAEAFF 39 8.21% TRBV7–8 TRBJ1–1 TRBD1
  CASSPDRGDEQFF 39 6.23% TRBV12–3 TRBJ2–1 TRBD1
NR3 CASSSGQDTEAFF 39 8.56% TRBV9 TRBJ1–1 TRBD1
  CASSPQGAYEQYF 39 8.39% TRBV9 TRBJ2–7 TRBD1
  1. *R3 and NR2: no clonotype with a frequency > 5%